Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rongce Zhao

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Surgical Endoscopy|April 9, 2017
Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysisBenbo Zheng, Rongce Zhao, Xiaodong Li, et al.
Frontiers in Immunology|May 27, 2024
Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinomaRongce Zhao, Jing Zhou, Zhaoxia Miao, et al.
Acta Biochimica Et Biophysica Sinica|December 13, 2019
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinomaZhongjian Liu, Mingmei Chen, Rongce Zhao, et al.
World Journal of Surgery|September 30, 2018
Hepatic Pedicle Occlusion with the Pringle Maneuver During Difficult Laparoscopic Cholecystectomy Reduces the Conversion RateRongce Zhao, Fei Liu, Chenyang Jia, et al.
American Journal of Cancer Research|November 18, 2024
Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinomaRongce Zhao, Jing Zhou, Xinhao Xiong, et al.
Journal of Hepatocellular Carcinoma|November 4, 2024
FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort StudyRongce Zhao, Jing Zhou, Zehao Zheng, et al.
Medicine|March 23, 2017
The prognostic role of BORIS and SOCS3 in human hepatocellular carcinomaRongce Zhao, Kefei Chen, Jing Zhou, et al.
Medicine|July 12, 2016
Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trialJing Zhou, Rongce Zhao, Feng Wen, et al.
European Journal of Medical Research|September 9, 2023
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapyMin Deng, Rongce Zhao, Renguo Guan, et al.
Molecular Medicine (Cambridge, Mass.)|February 6, 2022
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinomaMin Deng, Shiquan Sun, Rongce Zhao, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Surgical Endoscopy|April 9, 2017
Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysisBenbo Zheng, Rongce Zhao, Xiaodong Li, et al.
Frontiers in Immunology|May 27, 2024
Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinomaRongce Zhao, Jing Zhou, Zhaoxia Miao, et al.
Acta Biochimica Et Biophysica Sinica|December 13, 2019
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinomaZhongjian Liu, Mingmei Chen, Rongce Zhao, et al.
World Journal of Surgery|September 30, 2018
Hepatic Pedicle Occlusion with the Pringle Maneuver During Difficult Laparoscopic Cholecystectomy Reduces the Conversion RateRongce Zhao, Fei Liu, Chenyang Jia, et al.
American Journal of Cancer Research|November 18, 2024
Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinomaRongce Zhao, Jing Zhou, Xinhao Xiong, et al.
Journal of Hepatocellular Carcinoma|November 4, 2024
FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort StudyRongce Zhao, Jing Zhou, Zehao Zheng, et al.
Medicine|March 23, 2017
The prognostic role of BORIS and SOCS3 in human hepatocellular carcinomaRongce Zhao, Kefei Chen, Jing Zhou, et al.
Medicine|July 12, 2016
Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trialJing Zhou, Rongce Zhao, Feng Wen, et al.
European Journal of Medical Research|September 9, 2023
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapyMin Deng, Rongce Zhao, Renguo Guan, et al.
Molecular Medicine (Cambridge, Mass.)|February 6, 2022
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinomaMin Deng, Shiquan Sun, Rongce Zhao, et al.
Pageof 3